Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06552559
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, CNS Metastases
- Locations
-
- Samsung Cancer Research Institute Seoul, South Korea
- Samsung Medical Center Seoul, South Korea
NCT06378190
- Conditions
- B-cell Lymphoma Recurrent, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Hospital Clínic Barcelona, Spain
- Institut Català d'Oncologia Hospital L'Hospitalet de Llobregat, Barcelona, Spain
- Fundación Jiménez Díaz Hospital Madrid, Spain
- Virgen de la Arrixaca University Hospital El Palmar, Mur, Spain
NCT05705570
- Conditions
- Acute Lymphoblastic Leukemia Refractory, Acute Lymphoblastic Leukemia, in Relapse, B-cell Lymphoma Recurrent, +14 more
- Locations
-
- Hospital Israelita Albert Einstein São Paulo, Brazil
NCT06445803
- Conditions
- Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, in Relapse, B-cell Lymphoma Recurrent, +12 more
- Locations
-
- The First Affiliated Hospital of Nanchang University; Nanchang, Jiangxi, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma
NCT05909098
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, NK Cell
- Locations
-
- EC of Xiangyang No.1 People's Hospital Hubei University of Medicine Hubei, Xiangyang, China
Completed
MB-CART20.1 Lymphoma
NCT03664635
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, Disease Attributes, +15 more
- Locations
-
- University Hospital of Cologne - Clinic for Internal Medicine I Cologne, Germany
- Universitätsklikum Leipzig, AöR Leipzig, Germany
NCT05130489
- Conditions
- B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, +30 more
- Locations
-
- University College London Hospitals London, United Kingdom
NCT02843061
- Conditions
- B-cell Lymphoma Recurrent
- Locations
-
- Cancer Institute in Fuda cancer hospital Guangzhou, Guangdong, China
Active, Not Recruiting
MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
NCT03853616
- Conditions
- Acute Lymphoblastic Leukemia Recurrent, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, +2 more
- Locations
-
- Charité - University clinic, pediatric clinic with focus on oncology and hematology Berlin, Germany
- Universitätsklinikum Erlangen Erlangen, Germany
- University medicine Goettingen, Clinic of hematology and medical oncology Göttingen, Germany
- Children's Hospital of Dr. von Hauner by Ludwig-Maximilian University Munich, Germany
Active, Not Recruiting
Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
NCT04531046
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory
- Locations
-
- CH Liège Liège, Belgium
- CHU de Bordeaux - Hôpital Haut Lévêque Bordeaux, France
- CHU Clermont Ferrand - Hôpital Estaing Clermont-Ferrand, France
- APHP - Hôpital Henri Mondor Créteil, France
Active, Not Recruiting
CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies
NCT04214886
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, +19 more
- Locations
-
- Loyola University Maywood, Illinois, United States